{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T20:02:38Z","timestamp":1779739358543,"version":"3.53.1"},"reference-count":30,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100014147","name":"University of Rzesz\u00f3w Center for Innovation and Transfer of Natural Sciences and Engineering Knowledge","doi-asserted-by":"publisher","award":["2023020201010200"],"award-info":[{"award-number":["2023020201010200"]}],"id":[{"id":"10.13039\/501100014147","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.ijantimicag.2026.107783","type":"journal-article","created":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T16:46:44Z","timestamp":1773938804000},"page":"107783","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Population pharmacokinetics and dosing regimen optimization of ceftazidime in plasma and cerebrospinal fluid of neonatal sepsis patients"],"prefix":"10.1016","volume":"67","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-6831-5059","authenticated-orcid":false,"given":"Zuo","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingying","family":"Xin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengliu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8178-813X","authenticated-orcid":false,"given":"Xuwei","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyao","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingkong","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8637-207X","authenticated-orcid":false,"given":"Yang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2026.107783_bib0001","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S2213-2600(18)30063-8","article-title":"The global burden of paediatric and neonatal sepsis: a systematic review","volume":"6","author":"Fleischmann-Struzek","year":"2018","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.ijantimicag.2026.107783_bib0002","doi-asserted-by":"crossref","DOI":"10.1001\/jamapediatrics.2020.0593","article-title":"Early-onset neonatal sepsis 2015 to 2017, the rise of Escherichia coli, and the need for novel prevention strategies","volume":"174","author":"Stoll","year":"2020","journal-title":"JAMA Pediatr"},{"key":"10.1016\/j.ijantimicag.2026.107783_bib0003","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/s13756-021-00989-6","article-title":"Pathogens distribution and antimicrobial resistance in bloodstream infections in twenty-five neonatal intensive care units in China, 2017-2019","volume":"10","author":"Liu","year":"2021","journal-title":"Antimicrob Resist Infect Control"},{"key":"10.1016\/j.ijantimicag.2026.107783_bib0004","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1097\/INF.0000000000002492","article-title":"Early-onset sepsis among preterm neonates in China, 2015 to 2018","volume":"38","author":"Jiang","year":"2019","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.ijantimicag.2026.107783_bib0005","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1186\/s12887-020-02103-y","article-title":"Late-onset neonatal sepsis in Suzhou, China","volume":"20","author":"Pan","year":"2020","journal-title":"BMC Pediatr"},{"key":"10.1016\/j.ijantimicag.2026.107783_bib0006","first-page":"931","article-title":"[Expert consensus on diagnosis and management of neonatal bacteria sepsis (2024)]","volume":"62","year":"2024","journal-title":"Zhonghua Er Ke Za Zhi"},{"key":"10.1016\/j.ijantimicag.2026.107783_bib0007","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2021.105868","article-title":"Population pharmacokinetics-pharmacodynamics of ceftazidime in neonates and young infants: dosing optimization for neonatal sepsis","volume":"163","author":"Li","year":"2021","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.ijantimicag.2026.107783_bib0008","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1007\/s40262-023-01230-w","article-title":"Optimization of \u03b2-lactam dosing regimens in neonatal infections: continuous and extended administration versus intermittent administration","volume":"62","author":"Leegwater","year":"2023","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.ijantimicag.2026.107783_bib0009","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1086\/510079","article-title":"Pharmacokinetics-pharmacodynamics of antimicrobial therapy: it\u2019s not just for mice anymore","volume":"44","author":"Ambrose","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2026.107783_bib0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1086\/516284","article-title":"Pharmacokinetic\/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men","volume":"26","author":"Craig","year":"1998","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2026.107783_bib0011","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1592\/phco.26.9.1320","article-title":"Application of antimicrobial pharmacodynamic concepts into clinical practice: focus on beta-lactam antibiotics: insights from the Society of Infectious Diseases Pharmacists","volume":"26","author":"Lodise","year":"2006","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.ijantimicag.2026.107783_bib0012","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1136\/archdischild-2020-321426","article-title":"Pharmacokinetics and safety\/tolerability of isoniazid, rifampicin and pyrazinamide in children and adolescents treated for tuberculous meningitis","volume":"107","author":"Ruslami","year":"2022","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.ijantimicag.2026.107783_bib0013","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1007\/s40262-015-0291-1","article-title":"Pharmacokinetic studies in neonates: the utility of an opportunistic sampling design","volume":"54","author":"Leroux","year":"2015","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.ijantimicag.2026.107783_bib0014","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1016\/j.xphs.2017.12.018","article-title":"Population pharmacokinetics and dosing simulations of ceftazidime in Chinese neonates","volume":"107","author":"Wang","year":"2018","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.ijantimicag.2026.107783_bib0015","doi-asserted-by":"crossref","DOI":"10.1128\/aac.01707-22","article-title":"Population pharmacokinetics and dosing optimization of ceftazidime in term asphyxiated neonates during controlled therapeutic hypothermia","volume":"67","author":"van der Veer","year":"2023","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2026.107783_bib0016","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S0031-3955(16)36251-4","article-title":"The use of plasma creatinine concentration for estimating glomerular filtration rate in infants, children, and adolescents","volume":"34","author":"Schwartz","year":"1987","journal-title":"Pediatr Clin North Am"},{"key":"10.1016\/j.ijantimicag.2026.107783_bib0017","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1681\/ASN.2021101326","article-title":"Maturation of GFR in term-born neonates: an individual participant data meta-analysis","volume":"33","author":"Smeets","year":"2022","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.ijantimicag.2026.107783_bib0018","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1002\/cpt.1991","article-title":"Creatinine-based renal function assessment in pediatric drug development: an analysis using clinical data for renally eliminated drugs","volume":"109","author":"Zhang","year":"2021","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.ijantimicag.2026.107783_bib0019","doi-asserted-by":"crossref","first-page":"6619","DOI":"10.1128\/AAC.00997-16","article-title":"Population pharmacokinetics and dosing regimen optimization of meropenem in cerebrospinal fluid and plasma in patients with meningitis after neurosurgery","volume":"60","author":"Lu","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2026.107783_bib0020","doi-asserted-by":"crossref","first-page":"e02486","DOI":"10.1128\/AAC.02486-17","article-title":"Population pharmacokinetics and dosing optimization of ceftazidime in infants","volume":"62","author":"Shi","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2026.107783_bib0021","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1093\/jac\/dkz065","article-title":"Population pharmacokinetics of continuous-infusion ceftazidime in febrile neutropenic children undergoing HSCT: implications for target attainment for empirical treatment against Pseudomonas aeruginosa","volume":"74","author":"Cojutti","year":"2019","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2026.107783_bib0022","doi-asserted-by":"crossref","first-page":"e02336","DOI":"10.1128\/AAC.02336-18","article-title":"Population pharmacokinetics and dosing optimization of amoxicillin in neonates and young infants","volume":"63","author":"TANG","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2026.107783_bib0023","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1128\/CMR.00007-10","article-title":"Penetration of drugs through the blood-cerebrospinal fluid\/blood-brain barrier for treatment of central nervous system infections","volume":"23","author":"Nau","year":"2010","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.ijantimicag.2026.107783_bib0024","unstructured":"Clinical and Laboratory Standards Institute. (2025). Performance standards for antimicrobial susceptibility testing (35th ed., CLSI M100). Retrieved November 3, 2025. Available from http:\/\/www.clsi.org."},{"key":"10.1016\/j.ijantimicag.2026.107783_bib0025","unstructured":"U.S. Food and Drug Administration. (2023). Ceftazidime injection products. Retrieved September 10, 2025. Available from: https:\/\/www.fda.gov\/drugs\/development-resources\/ceftazidime-injection-products."},{"key":"10.1016\/j.ijantimicag.2026.107783_bib0026","unstructured":"Model Formulary for Children. (2010). Switzerland: World Health Organization. Retrieved September 12, 2025. Available from: https:\/\/www.who.int\/publications\/i\/item\/9789241599320."},{"key":"10.1016\/j.ijantimicag.2026.107783_bib0027","unstructured":"British National Formulary for Children. (2015). London, United Kingdom: Royal Pharmaceutical Society of Great Britain. Retrieved September 12, 2025. Available from:https:\/\/www.nice.org.uk\/bnfc-uk-only."},{"key":"10.1016\/j.ijantimicag.2026.107783_bib0028","doi-asserted-by":"crossref","first-page":"2891","DOI":"10.1093\/jac\/dkx209","article-title":"Too much of a good thing: a retrospective study of \u03b2-lactam concentration-toxicity relationships","volume":"72","author":"Imani","year":"2017","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2026.107783_bib0029","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.18234","article-title":"Extended-infusion \u03b2-lactam therapy, mortality, and subsequent antibiotic resistance among hospitalized adults with Gram-negative bloodstream infections","volume":"7","author":"Karaba","year":"2024","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.ijantimicag.2026.107783_bib0030","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1128\/AAC.00936-09","article-title":"Population pharmacokinetic comparison and pharmacodynamic breakpoints of ceftazidime in cystic fibrosis patients and healthy volunteers","volume":"54","author":"Bulitta","year":"2010","journal-title":"Antimicrob Agents Chemother"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857926000725?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857926000725?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T19:04:33Z","timestamp":1779735873000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857926000725"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":30,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S0924857926000725"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2026.107783","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Population pharmacokinetics and dosing regimen optimization of ceftazidime in plasma and cerebrospinal fluid of neonatal sepsis patients","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2026.107783","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd and International Society of Antimicrobial Chemotherapy. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107783"}}